Emerging within the UK, retatrutide, a innovative molecule, is sparking considerable interest within the medical community regarding its promise for weight management . This dual GIP and GLP-1 agent agonist seems to provide a substantial advantage over existing therapies, showing positive results in early clinical trials . Researchers suggest its u